MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Magnesium glycerophosphate

Magnesium glycerophosphate (magnesium 9.72mg (0.4mmol)) capsules

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 9.72mg (0.4mmol)) capsules

There are no stability notes for this medicine.

Supplier

Magnesium glycerophosphate (magnesium 9.72mg (0.4mmol)) capsules (Special Order)

Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules

There are no stability notes for this medicine.

Suppliers

MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd)
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules (Special Order)
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd)

Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules

There are no stability notes for this medicine.

Suppliers (4) of Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules
Mag-4 (magnesium 48.6mg (2mmol)) capsules (Ennogen Healthcare International Ltd)
MagnaPhos 48.6mg (2mmol) capsules (TriOn Pharma Ltd)
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules (Special Order)
MagnEss Gly 48.6mg (2mmol) capsules (Essential-Healthcare Ltd)

Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) tablets

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) tablets

There are no stability notes for this medicine.

Supplier

Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) tablets (Special Order)

Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) capsules

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) capsules

There are no stability notes for this medicine.

Suppliers (4) of Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) capsules
Mag-4 (magnesium 97.2mg (4mmol)) capsules (Ennogen Healthcare International Ltd)
MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd)
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) capsules (Special Order)
MagnEss Gly 97.2mg (4mmol) capsules (Essential-Healthcare Ltd)

Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets

There are no stability notes for this medicine.

Supplier

YourMAG (magnesium 97.2mg (4mmol)) chewable tablets (Your Products Ltd)

Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free

There are no stability notes for this medicine.

Suppliers (5) of Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free
Mag-4 (magnesium 97.2mg (4mmol)) chewable tablets (Ennogen Healthcare International Ltd)
MagnaPhate (magnesium 97.2mg (4mmol)) chewable tablets (Arjun Products Ltd)
MagnaPhos 97.2mg (4mmol) chewable tablets (TriOn Pharma Ltd)
MagnEss Gly 97.2mg (4mmol) chewable tablets (Essential-Healthcare Ltd)
Neomag (magnesium 97mg (4mmol)) chewable tablets (Neoceuticals Ltd)

Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) tablets

No stability information

Stability notes for Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) tablets

There are no stability notes for this medicine.

Suppliers

Mag-4 (magnesium 97.2mg (4mmol)) tablets (Ennogen Healthcare International Ltd)
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) tablets (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.